American International Group
AIG
$76.29
+1.27%
American International Group (AIG) is a global insurance and financial services conglomerate operating through subsidiaries that provide property, casualty, and life insurance across more than 200 countries and jurisdictions. The company is a market leader in commercial insurance, particularly in the large corporate and specialty risk segments, and has been reshaping its portfolio through the spin-off of its life and retirement business, Corebridge Financial, while retaining a minority stake. The current investor narrative centers on AIG's ability to execute on its underwriting excellence strategy, improve combined ratios, and return capital to shareholders via buybacks and dividends, even as it faces a challenging property-casualty pricing environment and macroeconomic uncertainty. Recent headlines highlight the completion of the Corebridge separation, leadership transitions, and the company's focus on reducing volatility and enhancing return on equity, which are key to re-rating the stock.…
AIG
American International Group
$76.29
Investment Opinion: Should I buy AIG Today?
Based on the synthesis of analyst consensus, valuation, and fundamental trends, AIG warrants a Hold rating with a slight bullish tilt. The consensus recommendation is 'Buy' with an average target price of $88.50, implying 17.5% upside, but the stock's persistent revenue decline and relative underperformance temper enthusiasm. The core thesis is that AIG is a deep-value play trading at a forward PE of 8.57x, but it requires successful execution on earnings growth to unlock value.
Supporting evidence includes the attractive forward valuation, with a forward PE of 8.57x versus a trailing PE of 15.61x, and a PEG ratio of 0.25, suggesting undervaluation relative to expected growth. The dividend yield of 2.02% and payout ratio of 31.5% provide income support, while the debt-to-equity ratio of 0.223 reflects a strong balance sheet. However, revenue growth is negative at -1.83% year-over-year, and ROE of 7.53% is below the industry average, which may limit multiple expansion. Analyst targets range from $80 to $101, with the average at $88.50, indicating a favorable risk/reward if earnings materialize.
The biggest risks include a failure to achieve the consensus EPS of $9.47, which could lead to a sharp de-rating, and continued revenue declines that undermine the growth narrative. Additionally, the stock's technical downtrend and relative weakness versus the S&P 500 could persist if no catalyst emerges. The rating would upgrade to Buy if revenue growth turns positive or if the forward PE remains below 10x with improving ROE, and downgrade to Sell if revenue declines accelerate or if the stock breaks below the 52-week low of $71.25. Relative to its history, the PB ratio of 1.18x is above the 2022 low of 0.89x but below the 2021 level of 0.74x, suggesting the stock is fairly valued to slightly undervalued, but not a screaming bargain.
Sign up to view all
AIG 12-Month Price Forecast
AIG presents a mixed picture: deeply discounted forward valuation and analyst upside contrast with persistent revenue declines and relative underperformance. The stock's low beta and strong balance sheet provide downside protection, but without top-line growth, the upside is capped. The key to a bullish stance is achieving the consensus EPS of $9.47, which would likely drive multiple expansion. Conversely, a miss could push the stock toward its 52-week low. I would upgrade to bullish if revenue growth turns positive and ROE exceeds 10%, and downgrade to bearish if earnings disappoint or the stock breaks below $71.25. Given the current data, a neutral stance with a slight value tilt is appropriate.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on American International Group's 12-month outlook, with a consensus price target around $88.50 and implied upside of +16.0% versus the current price.
Average Target
$88.50
0 analysts
Implied Upside
+16.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$80 - $101
Analyst target range
AIG is covered by 20 analysts, with a consensus recommendation of "Buy" and an average target price of $88.50, implying a 17.5% upside from the current price of $75.33. The recommendation mean of 2.32 (on a scale where 1 is Strong Buy and 5 is Strong Sell) indicates a moderately bullish sentiment, though not overwhelmingly so. The distribution of ratings includes a mix of Buy, Hold, and a few Sell ratings, reflecting divergent views on the company's prospects. The consensus EPS estimate for the current year is $9.47, which would represent a significant increase from the trailing EPS of $0.064, highlighting expectations for a sharp earnings recovery. The target price range spans from a low of $80.00 to a high of $101.00, a spread of 26.3%, which signals considerable uncertainty about the company's future performance. The high target of $101 likely assumes successful execution of strategic initiatives, multiple expansion, and a favorable insurance pricing environment, while the low target of $80 implies modest growth and stable margins. Recent institutional ratings show a mix of actions: Piper Sandler downgraded to Neutral from Overweight in July 2026, while Cantor Fitzgerald upgraded to Overweight from Neutral, indicating shifting opinions. The wide target spread and recent rating changes suggest that analysts are divided on AIG's ability to unlock value, and the stock may remain volatile until clearer catalysts emerge.
Drowning in data?
Find the real signal!
Bulls vs Bears: AIG Investment Factors
The bear case currently has stronger evidence due to AIG's persistent revenue decline, severe relative underperformance, and technical downtrend. However, the bull case rests on a compelling forward valuation (8.57x forward PE) and analyst consensus upside of 17.5%, which could materialize if earnings recover as expected. The single most important tension is whether AIG can achieve the consensus EPS estimate of $9.47, which would justify a significant re-rating; failure to do so could lead to further multiple compression. The stock's low beta and conservative balance sheet provide some downside protection, but without top-line growth, the upside may be limited. Ultimately, the investment debate hinges on the sustainability of earnings improvement and the company's ability to return capital effectively.
Bullish
- Deep Forward PE Discount: AIG trades at a forward PE of 8.57x versus a trailing PE of 15.61x, implying the market expects earnings to more than double. The consensus EPS estimate of $9.47 for the current year, versus trailing EPS of $0.064, suggests a sharp recovery that could drive multiple expansion if delivered.
- Analyst Consensus Upside: The 20-analyst consensus rating is 'Buy' with an average target price of $88.50, representing 17.5% upside from the current $75.33. Even the lowest target of $80.00 implies 6.2% upside, indicating a favorable risk/reward skew.
- Conservative Balance Sheet: AIG's debt-to-equity ratio of 0.223 is well below the industry average, and its current ratio of 0.853 is adequate for an insurer. This financial flexibility supports continued capital returns via dividends (2.02% yield) and share buybacks.
- Improving Profitability Metrics: Q1 2026 net margin improved to 11.47% from 10.30% a year earlier, while gross margin jumped to 47.74% from 31.81%. Operating margin of 14.84% and ROE of 7.53% show progress, though ROE remains below historical peaks.
Bearish
- Persistent Revenue Decline: Q1 2026 revenue fell 1.83% year-over-year to $6.65 billion, continuing a volatile trend with no consistent growth. The lack of top-line expansion suggests limited pricing power and competitive pressures in the insurance market.
- Severe Relative Underperformance: AIG's 1-year price change of -4.31% drastically lags the S&P 500's +16.22% gain, resulting in a relative strength of -20.53%. The stock is down 10.61% year-to-date and sits just 5.7% above its 52-week low of $71.25.
- Earnings Volatility and Low ROE: Trailing EPS of $0.064 reflects past losses, including a -$6.02 EPS in Q2 2024. ROE of 7.53% is moderate for the insurance sector and below AIG's historical peaks, limiting the potential for a valuation re-rating.
- Wide Analyst Target Spread: The target price range spans from $80 to $101, a 26.3% spread, signaling significant uncertainty. Recent rating changes, including a Piper Sandler downgrade to Neutral, highlight divergent views on AIG's ability to unlock value.
AIG Technical Analysis
AIG is in a sustained downtrend, with the current price of $75.33 sitting just 5.7% above its 52-week low of $71.25 and 13.7% below its 52-week high of $87.29, placing it in the lower quartile of its annual range. The 1-year price change of -4.31% significantly lags the S&P 500's +16.22% gain, reflecting persistent relative weakness and a lack of positive momentum. This positioning suggests the stock is in a consolidation phase near multi-year lows, which could represent a value opportunity if fundamentals stabilize, but also signals caution as the market has yet to reward the company's strategic initiatives. Recent momentum remains negative, with a 1-month decline of -1.06% and a 3-month drop of -0.54%, both underperforming the broader market's -1.06% and +3.04% moves, respectively. The 6-month change of -1.84% and year-to-date decline of -10.61% further confirm the bearish trend, with no clear signs of a reversal. Relative strength metrics are deeply negative across all timeframes, including a -20.53% underperformance over the past year, indicating that AIG is a laggard in the current market environment. Key technical levels to watch are support at the 52-week low of $71.25 and resistance at the 52-week high of $87.29. A breakdown below $71.25 would likely trigger further selling pressure and signal a deeper downtrend, while a breakout above $87.29 would require a significant catalyst to reverse the current trajectory. The stock's beta of 0.511 indicates it is roughly half as volatile as the broader market, which may appeal to risk-averse investors but also means it will likely underperform in strong bull markets. The maximum drawdown of -16.98% over the past year highlights the stock's vulnerability to market corrections, though its low beta suggests it may offer some downside protection.
Beta
0.51
0.51x market volatility
Max Drawdown
-17.0%
Largest decline past year
52-Week Range
$71-$87
Price range past year
Annual Return
-3.3%
Cumulative gain past year
| Period | AIG Return | S&P 500 |
|---|---|---|
| 1m | -0.5% | -2.0% |
| 3m | +1.4% | +1.4% |
| 6m | +2.6% | +15.0% |
| 1y | -3.3% | +15.7% |
| ytd | -9.5% | +11.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AIG Fundamental Analysis
AIG's revenue trajectory has been uneven, with the most recent quarter (Q1 2026) showing revenue of $6.65 billion, a 1.83% year-over-year decline from $6.774 billion in Q1 2025. The multi-quarter trend reveals volatility: Q4 2025 revenue was $6.557 billion, Q3 2025 was $6.402 billion, and Q2 2025 was $7.041 billion, indicating no consistent growth pattern. The General Insurance segment, which generated $6.72 billion in the latest period, is the primary revenue driver, while corporate and reconciling items are minor. The lack of top-line growth is a concern for investors, as it suggests limited pricing power or exposure to competitive pressures in the insurance market. Profitability remains solid, with Q1 2026 net income of $763 million and a net margin of 11.47%, up from 10.30% in Q1 2025. The gross margin in Q1 2026 was 47.74%, a significant improvement from 31.81% in the prior-year quarter, though this metric can be volatile due to insurance accounting. Operating margin stood at 14.84%, and return on equity (ROE) was 7.53%, which is moderate for the insurance sector but below the company's historical peaks. The company's balance sheet is conservatively managed, with a debt-to-equity ratio of 0.223, well below the industry average, and a current ratio of 0.853, indicating adequate liquidity. Free cash flow for the trailing twelve months was $3.525 billion, providing ample capacity to fund dividends (yield 2.02%) and share repurchases. However, the cash flow coverage ratio of 0.017 is low, reflecting the capital-intensive nature of insurance operations. Overall, AIG's financial health is stable, but the lack of revenue growth and modest ROE may limit upside unless management can unlock value through further operational improvements.
Quarterly Revenue
$6.7B
2026-03
Revenue YoY Growth
-1.8%
YoY Comparison
Gross Margin
47.7%
Latest Quarter
Free Cash Flow
$3.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AIG Overvalued?
Given AIG's positive net income of $763 million in Q1 2026, the price-to-earnings (PE) ratio is the primary valuation metric. The trailing PE is 15.61x, while the forward PE is 8.57x, implying the market expects significant earnings growth in the coming year. This wide gap between trailing and forward multiples suggests that analysts anticipate a substantial rebound in profitability, possibly driven by lower catastrophe losses, improved underwriting, or capital returns. Compared to the insurance sector, where the average PE is often in the 12-15x range, AIG's trailing PE of 15.61x is slightly above the midpoint, but the forward PE of 8.57x represents a deep discount. The price-to-book (PB) ratio of 1.18x is also modest, below the sector average of 1.5x, indicating the stock is not expensive relative to its book value. The PEG ratio of 0.25 is exceptionally low, suggesting that the stock is undervalued relative to its expected earnings growth, though this may reflect skepticism about the sustainability of growth. Historically, AIG's PE ratio has ranged from as low as 3.1x in 2022 to over 400x in 2023 due to earnings volatility. The current trailing PE of 15.61x is near the higher end of its recent range, but the forward PE of 8.57x is more attractive. The PB ratio of 1.18x is above the 2022 lows of 0.89x but below the 2021 level of 0.74x, suggesting the stock is trading at a moderate valuation relative to its own history. If the company can deliver on earnings growth, the forward multiple could compress further, offering upside.
PE
15.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 3x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
7.3x
Enterprise Value Multiple
Investment Risk Disclosure
AIG faces financial and operational risks stemming from its uneven revenue trajectory and earnings volatility. Revenue declined 1.83% year-over-year in Q1 2026 to $6.65 billion, with no consistent growth pattern across recent quarters. The company's ROE of 7.53% is moderate and below historical peaks, while the cash flow coverage ratio of 0.017 is low, reflecting the capital-intensive nature of insurance operations. Additionally, AIG's earnings have been volatile, including a -$6.02 EPS in Q2 2024, which highlights susceptibility to catastrophe losses and reserve adjustments.
Market and competitive risks include valuation compression if earnings fail to meet the optimistic forward estimates. The forward PE of 8.57x implies significant earnings growth, but if AIG misses expectations, the multiple could revert to the trailing level of 15.61x, causing price depreciation. The stock's beta of 0.511 indicates lower market correlation, but it also means AIG may underperform in strong bull markets. Competitive pressures in the property-casualty insurance sector, particularly in commercial lines, could limit pricing power and margin expansion. Recent analyst actions, such as Piper Sandler's downgrade to Neutral, reflect concerns about the company's ability to execute on its strategic initiatives.
In a worst-case scenario, a combination of revenue stagnation, higher catastrophe losses, and a failure to achieve consensus EPS could drive the stock down to its 52-week low of $71.25, representing a 5.4% decline from the current price of $75.33. If the broader market enters a correction, AIG's low beta might not fully protect it, and the stock could test the analyst low target of $80, though that is above the current price. A more severe downside could see the stock fall to the 2022 lows, but based on available data, the maximum drawdown over the past year was -16.98%, suggesting a realistic bear-case loss of around 17% from the current price, or approximately $62.50, though this is below the 52-week low. Investors should note that the 52-week low of $71.25 is a key support level; a break below could accelerate losses.
FAQ
The most severe risk is earnings disappointment, as the forward PE of 8.57x relies on achieving the consensus EPS of $9.47; a miss could trigger a sharp de-rating. Financial risks include revenue decline (-1.83% YoY) and moderate ROE (7.53%), which limit organic growth. Competitive and market risks involve pricing pressure in commercial insurance and relative underperformance versus the S&P 500 (-20.53% over 1 year). Company-specific risks include catastrophe losses and reserve adjustments, as seen in the -$6.02 EPS in Q2 2024. Additionally, the stock's technical downtrend and proximity to the 52-week low of $71.25 pose a risk of further selling if support breaks.
Our 12-month forecast assigns a 55% probability to the base case, targeting $85-$90, aligned with the analyst average of $88.50. The bull case (25% probability) targets $95-$101, contingent on EPS exceeding $9.47 and ROE improving above 10%. The bear case (20% probability) targets $71-$80, driven by earnings misses or higher catastrophe losses. The most likely scenario is the base case, assuming AIG meets consensus EPS and maintains stable margins. Key assumptions include no major reserve charges and flat revenue growth. The wide target range reflects significant uncertainty, so investors should monitor quarterly results closely.
AIG appears undervalued on a forward basis, with a forward PE of 8.57x versus a trailing PE of 15.61x, and a PEG ratio of 0.25. The price-to-book ratio of 1.18x is below the sector average of 1.5x, suggesting a discount to peers. However, the trailing PE is near the higher end of its recent range, and the stock's PB is above its 2022 low of 0.89x. The market is pricing in significant earnings growth, as evidenced by the consensus EPS estimate of $9.47 versus trailing EPS of $0.064. If AIG delivers, the stock is undervalued; if not, the current price may be fair or even optimistic. Relative to its own history, the valuation is moderate, not deeply distressed.
AIG may be a good buy for value-oriented investors with a medium-term horizon, given its forward PE of 8.57x and analyst average target of $88.50 (17.5% upside). However, the stock's revenue declined 1.83% year-over-year in Q1 2026, and it has underperformed the S&P 500 by 20.53% over the past year, indicating persistent weakness. The risk/reward is skewed favorably if earnings recover as expected, but the wide analyst target range ($80-$101) and recent downgrades suggest uncertainty. For income investors, the 2.02% dividend yield and low beta of 0.511 add appeal. Ultimately, it is a conditional buy: only if you believe in the earnings recovery story and can tolerate near-term volatility.
AIG is better suited for long-term investment (minimum 2-3 years) given its low beta of 0.511, dividend yield of 2.02%, and the time needed for its strategic initiatives to bear fruit. Short-term trading is less attractive due to the stock's lack of momentum and negative relative strength. The company's earnings visibility is moderate, with analyst estimates implying a sharp recovery, but execution risk is high. Long-term investors can benefit from potential multiple expansion and capital returns, while short-term traders may face range-bound action between $71 and $87. A buy-and-hold approach with a focus on quarterly earnings progress is recommended.
